Page last updated: 2024-12-08

baeocystin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

baeocystin: from Psilocybe semilanceata [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

baeocystin : A tryptamine alkaloid that is N-methyltryptamine carrying an additional phosphoryloxy substituent at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID161359
CHEMBL ID4634002
CHEBI ID139505
SCHEMBL ID20450791
MeSH IDM0061920

Synonyms (18)

Synonym
baeocystin
n-desmethylpsilocybin
4-hydroxy-n-methyltryptamine phosphate
21420-58-6
CHEBI:139505
3-[2-(methylamino)ethyl]-1h-indol-4-yl dihydrogen phosphate
[3-[2-(methylamino)ethyl]-1h-indol-4-yl] dihydrogen phosphate
1h-indol-4-ol, 3-(2-(methylamino)ethyl)-, dihydrogen phosphate (ester)
22kw205wf2 ,
beocystin
unii-22kw205wf2
3-(2-(methylammonio)ethyl)-1h-indol-4-yl hydrogen phosphate
DTXSID70175693
Q419475
SCHEMBL20450791
C21779
({3-[2-(methylamino)ethyl]-1h-indol-4-yl}oxy)phosphonic acid
CHEMBL4634002
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
hallucinogenDrugs capable of inducing illusions, hallucinations, delusions, paranoid ideations and other alterations of mood and thinking.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
organic phosphate
tryptamine alkaloid
secondary amino compoundA compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1648178Induction of head-twitch response in C57BL/6J mouse at 0.03 to 3 mg/kg, ip measured for 20 mins2020Journal of natural products, 02-28, Volume: 83, Issue:2
Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's2 (22.22)18.2507
2000's0 (0.00)29.6817
2010's3 (33.33)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.00 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index65.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]